Patients Prefer Doctors Who Engage in Face-to-Face Visits

Share this content:
Patients Prefer Doctors Who Engage in Face-to-Face Visits
Patients Prefer Doctors Who Engage in Face-to-Face Visits

MONDAY, April 23, 2018 (HealthDay News) -- Patients prefer physicians who engage in face-to-face (F2F) clinic visits, rather than those using an examination room computer (ERC), according to a research letter published online April 19 in JAMA Oncology.

Ali Haider, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues conducted a randomized controlled crossover study involving 120 patients from a palliative care clinic. Patients' perceptions of physicians' compassion were assessed after watching two standardized scripted-video vignettes of physicians: one portraying F2F clinic visits and one portraying a physician using an ERC. After viewing each video, patients completed questionnaires rating physicians' compassion, communication skills, and professionalism.

The researchers found that after watching and assessing the first video, the F2F visit resulted in better scores for compassion, communication skills, and professionalism. Better compassion, communication skills, and professionalism scores were also seen for the F2F visit after crossover analysis. Seventy-one percent of patients preferred the F2F physician.

"Proper optimization of the ERC and clinicians' training might improve patients' perception," the authors write. "Because current health care delivery necessitates the use of electronic health records, future studies focusing on strategies that can mitigate the negative effects of the ERC use on physician-patient communication are imperative."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »